BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2009
View Archived Issues
Final data reported from phase Ib trial of atacicept in pretreated CLL patients
Read More
Romiplostim safe and effective in phase I/II study in pediatric ITP patients
Read More
Preliminary phase I safety and efficacy of IMGN-901 seen in pretreated MM patients
Read More
Novel TGR5 receptor agonists identified by AstraZeneca for type 2 diabetes treatment
Read More
Chroma Therapeutics describes novel Plk-1 inhibitors for cancer therapy
Read More
BMS identifies novel nAChR agonists
Read More
Biovitrum advances novel long-acting factor VIII-based hemophilia A therapy
Read More
FDA approves newly revised prescribing information for Teva's Azilect
Read More
Warner Chilcott affirms agreement with sanofi-aventis
Read More
Clinical data on candesartan in diabetic retinopathy disclosed at ISOPT
Read More
Pilot trial data indicate beneficial effects of Copaxone in dry AMD
Read More
Vorinostat in combination with tamoxifen safe and effective in phase II breast cancer trial
Read More
Daiichi Sankyo presents novel antibacterial compounds
Read More
Columbia University identifies VMAT2 ligands for the treatment of diabetes
Read More
Sanofi Pasteur expands study of Clostridium difficile vaccine to the U.S.
Read More
Celgene reports topline clinical phase IIb data on apremilast in psoriasis
Read More
Once-weekly exenatide superior to Byetta in type 2 diabetes patients
Read More
Nippon Shinyaku launches Erizas in Japan for the treatment of allergic rhinitis
Read More
Adcirca tablets launched by Nippon Shinyaku for pulmonary arterial hypertension
Read More
NDA submitted by Nippon Shinyaku for azacitidine in myelodysplastic syndromes
Read More
Novartis submits MAA to EMEA for Joulferon for hepatitis C
Read More
Primary endpoints unmet in Gilead's phase III darusentan trial in resistant hypertension
Read More
Lytix Biopharma obtains approval in Norway and Sweden for phase I trial of LTX-315
Read More
AstraZeneca and University of Virginia to collaborate on CAD and PDA therapies
Read More
Evotec receives milestone payment from Ono under collaboration on protease inhibitors
Read More